Management of drug–drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs

RJ Brüggemann, R Verheggen, E Boerrigter… - The Lancet …, 2022 - thelancet.com
Over the past 10 years, the number of targeted therapies for haematological malignancies
has substantially increased, and many new drugs have entered the market. Many of these …

Clinical, economic and humanistic outcomes of medication therapy management services: A systematic review and meta-analysis

ZJ Deng, L Gui, J Chen, SS Peng, YF Ding… - Frontiers in …, 2023 - frontiersin.org
Background: Medication therapy management (MTM) services is a method that can
effectively improve patients' conditions, but the efficacy of economic and humanistic …

Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain

M Schulz, N Griese-Mammen, U Müller - International Journal of Clinical …, 2023 - Springer
Over the last two decades, community pharmacy has experienced major changes as the role
of pharmacists is evolving from a product to a service and a patient focus. As part of this …

Nurses' responsibilities and tasks in pharmaceutical care: A scoping review

E De Baetselier, T Dilles, H Feyen… - Nursing …, 2022 - Wiley Online Library
Aim To provide an overview of responsibilities and tasks of nurses in pharmaceutical care.
Design Scoping review. Methods Two databases were systematically searched (MEDLINE …

Cost savings and waste reduction through redispensing unused oral anticancer drugs: the ROAD Study

EM Smale, BJF van den Bemt, ER Heerdink… - JAMA …, 2024 - jamanetwork.com
Importance New strategies targeting waste are required to improve financial and ecologic
sustainability of expensive therapies, such as oral anticancer drugs, that frequently remain …

Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?

E Peruzzi, R Roncato, E De Mattia… - British Journal of …, 2023 - Wiley Online Library
Adverse drug reactions (ADRs) account for a large proportion of hospitalizations among
adults and are more common in multimorbid patients, worsening clinical outcomes and …

Impact of pharmacist-led interventions on medication-related problems among patients treated for cancer: A systematic review and meta-analysis of randomized …

AM Fentie, SA Huluka, GT Gebremariam… - Research in Social and …, 2024 - Elsevier
Abstract Background Medication-related problems (MRPs) continue to impose a voluminous
health impact, particularly among patients on anti-cancer therapy, due to the nature and …

Medication errors during treatment with new oral anticancer agents: Consequences for clinical practice based on the AMBORA study

K Schlichtig, P Dürr, F Dörje… - Clinical Pharmacology & …, 2021 - Wiley Online Library
Patients treated with oral anticancer agents (eg, kinase inhibitors) are a high‐risk population
for medication errors due to, for example, polymedication, age, and limited adherence …

An integrated pharmacological counselling approach to guide decision-making in the treatment with CDK4/6 inhibitors for metastatic breast cancer

R Roncato, L Gerratana, L Palmero, S Gagno… - Frontiers in …, 2022 - frontiersin.org
A wide inter-individual variability in the therapeutic response to cyclin-dependent kinases 4
and 6 inhibitors (CDKis) has been reported. We herein present a case series of five patients …

[HTML][HTML] ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications

SM Belcher, E Mackler, B Muluneh, PK Ginex… - Oncology nursing …, 2022 - ncbi.nlm.nih.gov
PURPOSE: This evidence-based guideline intends to support patients, clinicians, and others
regarding interventions and processes to support patient adherence to oral anticancer …